Compare NUVB & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | CXT |
|---|---|---|
| Founded | 2018 | 1855 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | N/A | N/A |
| Metric | NUVB | CXT |
|---|---|---|
| Price | $6.01 | $50.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $10.44 | ★ $76.75 |
| AVG Volume (30 Days) | ★ 6.3M | 544.3K |
| Earning Date | 03-05-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.68 |
| Revenue | $26,748,000.00 | ★ $1,578,900,000.00 |
| Revenue This Year | $616.63 | $10.77 |
| Revenue Next Year | $202.59 | $6.56 |
| P/E Ratio | ★ N/A | $19.49 |
| Revenue Growth | ★ 1137.19 | 9.30 |
| 52 Week Low | $1.54 | $41.54 |
| 52 Week High | $9.75 | $69.00 |
| Indicator | NUVB | CXT |
|---|---|---|
| Relative Strength Index (RSI) | 29.46 | 50.55 |
| Support Level | $6.07 | $49.52 |
| Resistance Level | $6.63 | $52.26 |
| Average True Range (ATR) | 0.53 | 1.46 |
| MACD | -0.39 | 0.71 |
| Stochastic Oscillator | 11.03 | 77.08 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.